Standardized uptake value on positron emission tomography/computed tomography predicts prognosis in patients with locally advanced pancreatic cancer

Verfasser / Beitragende:
[Si-Liang Wang, Shuo Cao, Yu-Nan Sun, Rong Wu, Feng Chi, Mei-Yue Tang, Xue-Ying Jin, Xiao-Dong Chen]
Ort, Verlag, Jahr:
2015
Enthalten in:
Abdominal Imaging, 40/8(2015-10-01), 3117-3121
Format:
Artikel (online)
ID: 605494436
LEADER caa a22 4500
001 605494436
003 CHVBK
005 20210128100526.0
007 cr unu---uuuuu
008 210128e20151001xx s 000 0 eng
024 7 0 |a 10.1007/s00261-015-0544-3  |2 doi 
035 |a (NATIONALLICENCE)springer-10.1007/s00261-015-0544-3 
245 0 0 |a Standardized uptake value on positron emission tomography/computed tomography predicts prognosis in patients with locally advanced pancreatic cancer  |h [Elektronische Daten]  |c [Si-Liang Wang, Shuo Cao, Yu-Nan Sun, Rong Wu, Feng Chi, Mei-Yue Tang, Xue-Ying Jin, Xiao-Dong Chen] 
520 3 |a Background: The aim of the present study was to investigate the use and value of maximum standardized uptake value (SUVmax) on positron emission tomography/computed tomography (PET/CT) images as a prognostic marker for patients with locally advanced pancreatic cancer (LAPC). Materials and methods: The medical records of all consecutive patients who underwent PET/CT examination in our institution were retrospectively reviewed. Inclusion criteria were histologically or cytologically proven LAPC. Patients with distant metastasis were excluded. For statistical analysis, the SUVmax of primary pancreatic cancer was measured. Survival rates were calculated using the Kaplan-Meier method, and multivariable analysis was performed to determine the association of SUVmax with overall survival (OS) and progression-free survival (PFS) using a Cox proportional hazards model. Results: Between July 2006 and June 2013, 69 patients were enrolled in the present study. OS and PFS were 14.9months [95% confidence interval (CI) 13.1-16.7] and 8.3months (95% CI 7.1-9.5), respectively. A high SUVmax (>5.5) was observed in 35 patients, who had significantly worse OS and PFS than the remaining patients with a low SUVmax (P=0.025 and P=0.003). Univariate analysis showed that SUVmax and tumor size were prognostic factors for OS, with a hazard ratio of 1.90 and 1.81, respectively. A high SUVmax was an independent prognostic factor, with a hazard ratio of 1.89 (95% CI 1.015-3.519, P=0.045). Conclusion: The present study suggests that increased SUVmax is a predictor of poor prognosis in patients with LAPC. 
540 |a Springer Science+Business Media New York, 2015 
690 7 |a Locally advanced pancreatic carcinoma  |2 nationallicence 
690 7 |a Standardized uptake value  |2 nationallicence 
690 7 |a Positron emission tomography/computed tomography  |2 nationallicence 
690 7 |a Chemoradiotherapy  |2 nationallicence 
690 7 |a Prognosis  |2 nationallicence 
700 1 |a Wang  |D Si-Liang  |u Department of Medical Oncology, Shengjing Hospital of China Medical University, 36 Sanhao Road, 110004, Shenyang, China  |4 aut 
700 1 |a Cao  |D Shuo  |u Department of Medical Oncology, Shengjing Hospital of China Medical University, 36 Sanhao Road, 110004, Shenyang, China  |4 aut 
700 1 |a Sun  |D Yu-Nan  |u Department of Medical Oncology, Shengjing Hospital of China Medical University, 36 Sanhao Road, 110004, Shenyang, China  |4 aut 
700 1 |a Wu  |D Rong  |u Department of Medical Oncology, Shengjing Hospital of China Medical University, 36 Sanhao Road, 110004, Shenyang, China  |4 aut 
700 1 |a Chi  |D Feng  |u Department of Medical Oncology, Shengjing Hospital of China Medical University, 36 Sanhao Road, 110004, Shenyang, China  |4 aut 
700 1 |a Tang  |D Mei-Yue  |u Department of Medical Oncology, Shengjing Hospital of China Medical University, 36 Sanhao Road, 110004, Shenyang, China  |4 aut 
700 1 |a Jin  |D Xue-Ying  |u Department of Medical Oncology, Shengjing Hospital of China Medical University, 36 Sanhao Road, 110004, Shenyang, China  |4 aut 
700 1 |a Chen  |D Xiao-Dong  |u Department of Medical Oncology, Shengjing Hospital of China Medical University, 36 Sanhao Road, 110004, Shenyang, China  |4 aut 
773 0 |t Abdominal Imaging  |d Springer US; http://www.springer-ny.com  |g 40/8(2015-10-01), 3117-3121  |x 0942-8925  |q 40:8<3117  |1 2015  |2 40  |o 261 
856 4 0 |u https://doi.org/10.1007/s00261-015-0544-3  |q text/html  |z Onlinezugriff via DOI 
898 |a BK010053  |b XK010053  |c XK010000 
900 7 |a Metadata rights reserved  |b Springer special CC-BY-NC licence  |2 nationallicence 
908 |D 1  |a research-article  |2 jats 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-springer 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1007/s00261-015-0544-3  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Wang  |D Si-Liang  |u Department of Medical Oncology, Shengjing Hospital of China Medical University, 36 Sanhao Road, 110004, Shenyang, China  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Cao  |D Shuo  |u Department of Medical Oncology, Shengjing Hospital of China Medical University, 36 Sanhao Road, 110004, Shenyang, China  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Sun  |D Yu-Nan  |u Department of Medical Oncology, Shengjing Hospital of China Medical University, 36 Sanhao Road, 110004, Shenyang, China  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Wu  |D Rong  |u Department of Medical Oncology, Shengjing Hospital of China Medical University, 36 Sanhao Road, 110004, Shenyang, China  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Chi  |D Feng  |u Department of Medical Oncology, Shengjing Hospital of China Medical University, 36 Sanhao Road, 110004, Shenyang, China  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Tang  |D Mei-Yue  |u Department of Medical Oncology, Shengjing Hospital of China Medical University, 36 Sanhao Road, 110004, Shenyang, China  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Jin  |D Xue-Ying  |u Department of Medical Oncology, Shengjing Hospital of China Medical University, 36 Sanhao Road, 110004, Shenyang, China  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Chen  |D Xiao-Dong  |u Department of Medical Oncology, Shengjing Hospital of China Medical University, 36 Sanhao Road, 110004, Shenyang, China  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t Abdominal Imaging  |d Springer US; http://www.springer-ny.com  |g 40/8(2015-10-01), 3117-3121  |x 0942-8925  |q 40:8<3117  |1 2015  |2 40  |o 261